Galecto, Inc. financial data

Symbol
GLTO on Nasdaq
Industry
Pharmaceutical Preparations
Location
75 State Street, Suite 100, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 528 % +4.39%
Debt-to-equity 21.9 % -0.23%
Return On Equity -83.7 % +7.18%
Return On Assets -68.7 % +7.15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.1M shares +0.07%
Common Stock, Shares, Outstanding 27.1M shares +0.37%
Entity Public Float 58.9M USD
Weighted Average Number of Shares Outstanding, Basic 27.1M shares +2.81%
Weighted Average Number of Shares Outstanding, Diluted 27.1M shares +2.81%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.62M USD -75.8%
General and Administrative Expense 12.5M USD +3.78%
Operating Income (Loss) -26.6M USD +48.7%
Nonoperating Income (Expense) 1.19M USD +355%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.3M USD +50.7%
Income Tax Expense (Benefit) 42K USD
Net Income (Loss) Attributable to Parent -25.4M USD +50.7%
Earnings Per Share, Basic -0.92 USD/shares +54.2%
Earnings Per Share, Diluted -0.92 USD/shares +54.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.9M USD -0.41%
Marketable Securities, Current 6.08M USD -78.4%
Assets, Current 25.2M USD -54.5%
Property, Plant and Equipment, Net 67K USD -79.6%
Operating Lease, Right-of-Use Asset 76K USD -88%
Other Assets, Noncurrent 1.99M USD -19.9%
Assets 27.3M USD -53.6%
Accounts Payable, Current 724K USD -87%
Employee-related Liabilities, Current 1.26M USD -28.6%
Accrued Liabilities, Current 2.99M USD -68%
Liabilities, Current 3.71M USD -75.1%
Operating Lease, Liability, Noncurrent 66K USD -79.9%
Liabilities 3.71M USD -75.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 197K USD
Retained Earnings (Accumulated Deficit) -267M USD -10.5%
Stockholders' Equity Attributable to Parent 23.6M USD -46%
Liabilities and Equity 27.3M USD -53.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.94M USD +35%
Net Cash Provided by (Used in) Financing Activities 23K USD
Net Cash Provided by (Used in) Investing Activities 5.65M USD +311%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 27.1M shares +0.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.9M USD -0.41%
Deferred Tax Assets, Valuation Allowance 63.4M USD +18.6%
Deferred Tax Assets, Gross 63.4M USD +18.6%
Operating Lease, Liability 77K USD -87.7%
Depreciation 244K USD +294%
Payments to Acquire Property, Plant, and Equipment 43K USD -33.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -25.1M USD +50%
Lessee, Operating Lease, Liability, to be Paid 80K USD -88%
Property, Plant and Equipment, Gross 106K USD -75.1%
Operating Lease, Liability, Current 77K USD -81.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17K USD -94.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 16K USD -94.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3K USD -92.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10K USD -37.5%
Deferred Tax Assets, Operating Loss Carryforwards 52.4M USD +19.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 432K USD -23.1%
Additional Paid in Capital 290M USD +1.75%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 15K USD
Share-based Payment Arrangement, Expense 4.8M USD -14.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%